Therefore, understanding the precise mechanisms by which the Hippo-YAP pathway regulates the pathogenesis of AD could open avenues for targeted therapies to restore skin barrier function and mitigate inflammation. The gene discussed is YAP1; the disease is Alzheimer disease.